203 EFFECT OF SUPPLEMENTAL FOLLICLE-STIMULATING HORMONE OR EQUINE CHORIONIC GONADOTROPIN DURING THE PROTOCOL FOR TIMED AI IN HIGH-PRODUCING HOLSTEIN COWS

2010 ◽  
Vol 22 (1) ◽  
pp. 260 ◽  
Author(s):  
H. Ayres ◽  
R. M. Ferreira ◽  
M. C. Wiltbank ◽  
P. S. Baruselli

Programs that allow timed AI (TAI) have been used to improve reproductive efficiency in dairy herds; however, in many cases pregnancies per AI (P/AI) during these programs remain suboptimal. In the present experiment, it was hypothesized that treatment with FSH or eCG at the time of the PGF2 treatment of the TAI protocol would increase fertility in dairy cattle. This experiment was performed in June 2008 (winter) and January 2009 (summer) on 2 commercial dairy farms located in southeast Brazil. On a random day of the estrous cycle (Day 0), 694 cows at 196 ± 138 days in milk (DIM) received 2 mg of estradiol benzoate (RICB®, Tecnopec, São Paulo, Brazil) i.m. and a releasing intravaginal device (P4; Primer®, Tecnopec), which was removed on Day 8 when 150 μg of PGF (Prolise®, ARSA, Buenos Aires, Argentina) i.m. were administered. At this time, the cows were stratified by days in milk (DIM), parity, number of insemination, milk production, presence of a CL on Day 0, and body condition score (BCS) and were randomly assigned to 1 of 3 treatments: control (n = 232), consisting of no additional treatment; eCG (n = 232), consisting of 400 IU of eCG (Folligon®, Intervet, São Paulo, Brazil); and FSH (n = 230), consisting of 20 mg of FSH (Folltropin®, Bioniche, Belleville, Ontario, Canada). All cows received GnRH (100 μg of gonadorelin; Fertagyl®, Intervet) and were TAI 56 h after the removal of the device. Pregnancy diagnosis was performed 30 and 60 days after TAI. Also, a subset of animals (n = 89) was submitted to ultrasonographic exams to evaluate the diameter of the ovulatory follicles (ØOF), time to ovulation after P4 removal (TOV), and ovulation rate (OR). Statistical analyses were performed with logistic regression by PROC GLIMMIX of SAS (SAS Institute, Cary, NC, USA). There were no interactions of treatment with DIM, parity, number of insemination, BCS, locomotion score, sire, batch, inseminator, farm, or month; therefore, these variables were removed from the statistical model. The overall P/AI was different between treatments at 30 days after TAI [control = 28.0% (65/232), eCG = 29.7% (69/232), and FSH = 18.7% (43/230); P = 0.01], but not at 60 days [control = 21.6% (50/232), eCG = 24.1% (56/232), and FSH = 16.1% (37/230); P = 0.08]. Pregnancy loss was also similar among treatments [control = 23.1% (15/65), eCG = 18.8% (13/69), and FSH = 14.0% (6/43); P = 0.08]. In addition, the treatments (control, eCG, and FSH, respectively) were not different among ØOF (13.78 ± 0.52; 14.50 ± 0.59; and 15.35 ± 0.69 mm; P = 0.15); TOV (82.50 ± 2.14; 78.48 ± 2.35; and 78.96 ± 2.39 h after P4 withdrawal; P = 0.30); or OR [82.76% (24/29); 83.33% (25/30); and 83.33% (25/30); P = 0.44]. Thus, these data do not indicate a major fertility-enhancing effect of a single eCG or FSH treatment during protocol for TAI in high-producing dairy cows, contrary to the hypothesis of the present study. Tecnopec, Fazenda Campestre, Agrindus S/A, Echoa e Nutricell Nutrientes Celulares.

2010 ◽  
Vol 22 (1) ◽  
pp. 162
Author(s):  
J. Almeida ◽  
O. A. Resende ◽  
D. L. Silveira

With the goal of optimizing protocols, fixed-time artificial insemination (FTAI) was performed under field conditions in a study to evaluate conception rates in Girolando (5/8) heifers (18 to 24 months of age) treated with estradiol benzoate (BE) to induce ovulation. Forty heifers were allocated to 2 groups with 20 animals each: GI-sexed semen (2 million spermatozoa/dose) and GII-nonsexed semen (20 million spermatozoa/dose), with body condition score (BCS) of 3.0 ± 0.14 (scale of 1 to 5), middleweight of 335 ± 38 kg, so that it was made for reutilization of progesterone device. On Day 0 (morning), the animals received 2.0 mg of BE (RIC-BE®,Tecnopec, São Paulo, Brazil), 0.075 mg of D-cloprostenol (Prolise®, ARSA S.R.L., Buenos Aires, Argentina), and an intravaginal device of 1 g of progesterone (Primer®, Tecnopec). On Day 8 (morning) the device was removed and 0.075 mg of D-cloprostenol was managed in the GI animals, then these animals received 1.0 mg of BE 24 h after device removal. The insemination was in the late afternoon of Day 10 with a 6-hour delay (4 to 6 pm). The GII animals received Primer previously used for 8 days (being used in the GI animals under the same protocol). After pregnancy diagnosis at 60 days, a third group was created (GIII) using the not-pregnant animals of GI and GII. In GIII, Primer from third use [disinfected in solution Kilol®-L 1:250 (Quinabra, São Paulo, Brazil) and rinsed with water, dried, and packed in plastic sacks and kept for 60 days] was used following the GI protocol with sexed semen. There were no significant differences (P > 0.05) in the conception rates of 40, 58, and 65% among groups GI (8/20), GII (11/20), and GIII (13/20). These results indicate very good conception rates for heifers, contrary to recommendations of commercial companies of sexed semen that alert for the conception rate for mated animals to be lower when using FTAI and mating protocols in mass, compared with that of AI after estrus observation.


2010 ◽  
Vol 22 (1) ◽  
pp. 247
Author(s):  
J. R. V. Pimentel ◽  
P. H. P. Miguez ◽  
A. Kehrle ◽  
E. H. Madureira ◽  
F. A. Braga ◽  
...  

Progestagen-releasing devices are commonly used for fixed-time artificial insemination and fixed-time embryo transfer (FTET). The aim of this study was to evaluate the efficacy of a new progesterone-releasing intravaginal device made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactone (PCL; Progestar®, Innovare, São Paulo, Brazil) to synchronize crossbredcows and heifers for FTET by determining ovulation, conception, and pregnancy rates. A total of 205 recipients ranging in age from 2 to 8 years (heifers, n = 77; non-suckled cows, n = 69; suckled cows, n = 59) were used on 3 different farms during February, March, and April 2008. The experimental design was a generalized block design (cyclicity, body condition score, postpartum interval, and animal category, i.e. heifers, suckled, or non-suckled cows), with 2 different synchronization treatments for FTET (Progestar® v. Crestar®). Cows were assigned to either Crestar® (norgestomet ear implants; Intervet Schering-Plough, Kenilworth, NJ, USA; n = 103) or Progestar® (PHB-V; n = 102) treatments. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal or auricular device according to their group (Day 0). Together with P4 device withdrawal (Day 8), all animals received 400 IU of eCG i.m. (Novormon®, Schering-Plough) and 500 μg i.m. of PGF2α, (Sincrocio®, Ouro Fino, Brasil). On Day 9, all cows were treated with 1 mg of estradiol benzoate (Innovare) and the innovulation was performed on Day 17. Embryos were maintained at 37°C during the innovulation period. The percentage of usable recipients (AR) based on the presence of a functional CL on the day of embryo transfer, conception rate (numbers of pregnant recipients of the total number transferred; CR), and pregnancy rate (numbers of pregnant recipients of the total number synchronized; PR) were determined by ultrasonography 23 days after embryo transfer. Data were submitted to ANOVA (PROC GLM, SAS Institute Inc., Cary, NC, USA) and significant differences were considered to have a P-value of <0.05. None of the interactions were significant and there was no effect of treatment on AR (72.8% v. 83.3%), CR (47.9% v. 42.7%), and PR (34.7% v. 35.0%) for Progestar® v. Crestar® groups, respectively. This experiment showed that Progestar® was as efficacious as Crestar® to synchronize crossbred cows and heifers for FTET. FAPESP-Fundação de Amparo à Pesquisa do Estado de São Paulo and CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.


2009 ◽  
Vol 21 (1) ◽  
pp. 146
Author(s):  
V. G. Pinheiro ◽  
R. A. Satrapa ◽  
R. A. L. Simões ◽  
F. S. Rosa ◽  
C. M. Barros

There are reports in the literature indicating that the presence of calf, body condition score, number of births (multiparous v. primiparous), and breed are factors that influence the duration of postpartum anestrus in beef cows. The purpose of the present study was to evaluate, during early postpartum, the time of the reestablishment of LH stocks, measured by the hypothalamic-pituitary axis responsiveness to exogenous administration of gonadotropin-releasing hormone (GnRH) or estradiol benzoate (EB). Primiparous lactating Nellore cows (n = 38, body condition score 2.5 to 3.5, on a 0 to 5 scale) were kept in a Brachiaria brizantha pasture. The animals were randomly allocated into 2 groups, according to hormone treatment: EB group (1 mg EB, i.m., Estrogin®, Farmavet, Sao Paulo, Brazil; n = 20) and GnRH group (100 μg, licerelina, i.m, Gestran Plus®, ARSA S.L.R., Buenos Aires, Argentina; n = 18). In each group, half of the animals were supplemented with a balanced diet based on cotton meal and ground corn. The drugs were administered from 7 days postpartum (±4 days), at intervals of 7 days, until the occurrence of the first ovulation that was observed by weekly ultrasonography (US, Aloka 900, Tokyo, Japan; 7.5-MHz transrectal probe). The data were analyzed by ANOVA (Proc GLM, SAS Institute, Cary, NC). Within the GnRH and EB groups, the first ovulation occurred 15 and 33 days postpartum, respectively, whereas the group averages (± SD) occurred earlier in cows treated with GnRH compared with those treated with EB (43.0 ± 3.8. v. 75.1 ± 8.7 days postpartum, respectively; P < 0.01). In the EB group, 4 animals did not ovulate until Day 140 postpartum. There was no interaction of treatment (GnRH, EB) × nutrition (supplemented, nonsupplemented). When data from the EB and GnRH groups were combined, there was a significant difference between supplemented and nonsupplemented animals (44.4 ± 6.2 v. 68.9 ± 7.3 days, respectively; P < 0.02). The results indicate that GnRH induces ovulation from Day 15 postpartum, suggesting the presence of sufficient LH in the pituitary to induce the first ovulation at this time. However, EB administration did not induce ovulation in this period, possibly because of the sensitivity of the hypothalamus to negative feedback of estrogens, inhibiting the preovulatory LH surge. These results also indicate that nutritional supplementation anticipates the first postpartum ovulation induced by GnRH or EB. Support by FAPESP(Sao Paulo, Brazil); fellowship from FAPESPA; fellowship from CAPESB.


2010 ◽  
Vol 22 (1) ◽  
pp. 164
Author(s):  
F. A. Braga ◽  
F. J. D. Pardo ◽  
P. H. Miguez ◽  
A. Kehrle ◽  
J. R. V. Pimentel ◽  
...  

Artificial insemination results can be improved using fixed-timed AI (FTAI). Currently, progesterone release devices, indispensable in FTAI procedures, such as DIB® (Schering-Plough, Kenilworth, NJ, USA), are made of silicone, a nonbiodegradable biocompatible polymer. Recently, biodegradable progesterone (P4)-releasing devices made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactona (PCL) have been developed. To investigate the efficiency on pregnancy rate of FTAI programs using a new intravaginal device made of PHB-V (Progestar®, Innovare, São Paulo, Brazil), 240 Nellore (Bos indicus) cows, between 3 and 8 years of age, were randomly assigned to 2 experiments. In experiment 1, new P4 devices DIB (control group, DIB1; n = 60) were compared with PHB-V (Progestar1; n = 76); in experiment 2, previously used DIB (DIB2; n = 52) and PHB-V (Progestar2; n = 52) devices were compared. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal device according to group (Day 0). Together with P4 device withdrawal (Day 8) all animals received 300IU of eCG i.m. (Novormon®, Schering-Plough) and 150 μg i.m. of D-cloprostenol (Croniben®, Biogenesis-Bagó, Buenos Aires, Argentina). On Day 9, all cows were treated with 1 mg of estradiol benzoate and the FTAI was performed 30 h later. The data were submitted to ANOVA (PROC GLM of SAS, SAS Institute, Cary, NC, USA), separating as causes of variance the effect of treatment, postpartum period (PPP1-45 until 70 days and PPP2-71 until 90 days), body condition score (BCS4, BCS5, and BCS6 using a 1 to 9 scale), cyclicity (cycling and noncycling) and clean-up bulls (5 bulls nominated with numbers 1 to 5). Significant differences were considered to have P < 0.05. In experiment 1, interactions were not significant, there was no effect of treatment on FTAI (DIB1: 66.7% v. Progestar1: 65.8%) or breeding season pregnancy rates (BSPR; DIB1: 95.0% v. Progestar1: 94.7%) and no effect of other variables on FTAI pregnancy rates (FTAIPR) and BSPR. In experiment 2 there was no effect of treatment on FTAIPR (DIB2: 61.6% v. Progestar2: 55.8%) and BSPR (DIB2: 94.2% v. Progestar2: 88.5%). As ANOVA indicated a significant effect of clean-up bulls on BSPR, Tukey test was used to split it up. A bull of the Progestar2 group had lower performance (41.7%) causing the difference (albeit nonsignificant) on BSPR. This experiment showed that Progestar and DIB had the same efficiency on pregnancy rate and both treatments have the potential to produce FTAIPR >50% and BSPR >90%. Fapesp-Fundação de Amparo à Pesquisa do Estado de São Paulo. CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.


2010 ◽  
Vol 22 (1) ◽  
pp. 174
Author(s):  
V. A. Nascimento ◽  
G. S. Moura ◽  
M. Dias ◽  
F. A. Oliveira ◽  
A. R. Dias ◽  
...  

The objective of this study was to evaluate the administration of the follicle-stimulating hormone (FSH-p) or equine chorionic gonadotropin (eCG) in protocols of ovulation synchronization. One hundred forty-nine crossbred Holstein-Gyr cows were used in 2 properties in Minas Gerais and 3 treatments: TControl (n = 49 cows), Day 0: insert of a progesterone device (Primer®, Tecnopec, São Paulo, Brazil) + 2 mg of estradiol benzoate (RIC-BE®); Day 8: removal of Primer + 112 mg of D-cloprostenol (Prolise®, ARSA SRL, Buenos Aires, Argentina) + 1 mg of estradiol benzoate and fixed-time artificial insemination (FTAI) accomplished 44 h after the removal of Primer; TFSH (n = 50 cows), similar to TControl, but on Day 8, 15 mg of FSH-p (Folltropin®, Bioniche Animal Health) was administered; TeCG (n = 50 cows), similar to TControl, with administration on Day 8 of 300 IU of eCG (Novormon®, Syntex SA, Buenos Aires, Argentina). Cows that returned to estrus 14 to 28 days after the FTAI were inseminated once again. For all statistical analysis, we used the program SAS 9.0 (2002; SAS Institute Inc., Cary, NC, USA) at 5% probability. Quantitative variables (live weight, days postpartum, follicular average per cow) were analyzed by variance, and body condition score by Friedman test. The pregnancy rates were submitted to logistic analysis considering the effect of local experimental factors and were analyzed by Spearman correlation among the variables studied and the pregnancy rate. There was no difference (P > 0.05) between treatment for pregnancy rate in FTAI protocols (TControl = 40.82%; TFSH = 38.00%; TeCG = 26.00%), in the first insemination after FTAI (TControl = 56.25%; TFSH = 70.59%; TeCG = 68.42%), and in FTAI plus first insemination after FTAI (TControl = 59.18%; TFSH =62.00%; TeCG = 52.00%), as well as for the estrus repetition (TControl = 55.17%; TFSH = 54.84%; TeCG = 51.35%) and the correlation (P > 0.05) among the pregnancy rate and postpartum period, milk production, body weight and body condition. No effect was observed on the pregnancy rate by the addition of the hormones FSH and eCG in the protocol of ovulation synchronization in crossbred Holstein-Gyr cows; however, reinsemination in the period from 14 to 28 days after FTAI increased the pregnancy rate. CNPq; FAPEMIG; TECNOPEC/São Paulo, Brazil.


2013 ◽  
Vol 25 (1) ◽  
pp. 151
Author(s):  
J. T. M. Lima ◽  
J. F. Fonseca ◽  
L. V. Esteves ◽  
A. B. V. Peneiras ◽  
M. S. D. Lima ◽  
...  

The aim of this study was to determine the intervals between sponge removal and the onset of estrus, sponge removal and the first detected ovulation, and onset of estrus and the first ovulation, and also to determine the duration of estrus, in superovulated Santa Inês ewes subjected to natural mating (NM) and AI. The trial was done in July and February at Cachoeiras de Macacu–Rio de Janeiro (22°27′S, 43°39′W). Fifteen non-pregnant Santa Inês ewes, age 3.4 ± 1.4 years, weighing 47.8 ± 6.3 kg, with 3.3 ± 0.4 body condition score (scale of 1 to 5), were randomly assigned to 2 groups. Both groups were superovulated using the same protocol and were mated in a crossover design by NM and laparoscopic AI. Estrus was synchronized using intravaginal sponges (60 mg of medroxyprogesterone acetate; Progespon®, Schering Plough Animal Health, São Paulo, Brazil) inserted (Day 0) and maintained for 6 days. On Day 5, the ewes received IM injections of 300 IU of eCG (Novormon®, Schering Plough Animal Health) and 0.0375 mg of cloprostenol (Prolise®, Tecnopec, São Paulo, Brazil). Twelve hours after sponge removal, 0.025 mg of gonadorelin acetate (Gestran®, Tecnopec) was administered IM. Superovulation started 60 h after sponge removal and consisted of 5 IU kg–1 of porcine FSH (pFSH; Pluset®, Hertape Calier, Minas Gerais, Brazil) IM in 6 decreasing doses (25, 25, 15, 15, 10, and 10%) at 12-h intervals. At the first pFSH dose, new sponges were inserted. At the fifth pFSH dose, 0.0375 mg of cloprostenol was administered IM and the sponges were removed. After the sponge removal, the NM group was exposed to rams twice per day for mating, until the end of estrus. In the AI group, estrus was detected using a teaser with the penis diverted. The females were permitted to be mounted twice per day until the end of estrus, and were inseminated with frozen–thawed semen 24 and 36 h after the end of superovulation. The follicular development and ovulation time were observed using real-time ultrasonography (8.0 MHz Pie Medical®, Aquila Vet, Tokyo, Japan) at 12-h intervals. For statistical analysis, a Student’s t-test was performed (5% significance level) using the BioEstat program. Results are presented as mean ± standard deviation. The time from sponge removal to onset of estrus and the duration of estrus did not differ between NM and AI groups (31.79 ± 5.94 v. 25.25 ± 10.38 h and 29.89 ± 11.54 v. 26.66 ± 8.67 h, respectively). The time from sponge removal to ovulation and from onset of estrus to the first ovulation were shorter (P < 0.001) in the NM group (32.11 ± 12.72 v. 56.48 ± 15.39 h and 8.61 ± 5.99 v. 32.25 ± 18.57 h, respectively). The time from sponge removal to ovulation in July and February was 56.07 ± 7.27 versus 56.83 ± 20.72 in the AI group and 29.54 ± 0.56 versus 33.83 ± 19.02 in the NM group, respectively, suggesting that the season of the year in a tropical region did not influence the ovulation time for each treatment. Possibly, the mechanical stimulation induced by the contact of the penis with the vagina fornix and by the accessory sex glands fluids in mating hastened the ovulation time in the NM group. The service can shorten the time of ovulation.


2016 ◽  
Vol 68 (5) ◽  
pp. 1159-1167 ◽  
Author(s):  
R.D. Tortorella ◽  
M.R. Modesto ◽  
J.P. Neves ◽  
A.F. Ramos

ABSTRACT Two experiments were conducted aiming to evaluate the effects of two ovulatory inducers (Exp.1) and equine chorionic gonadotropin (eCG; Exp.2) on follicular and luteal dynamics in a fixed-time AI (FTAI) protocol in locally adapted Curraleiro Pé-Duro cows. In Exp. 1 multiparous cows (n=12) received an intravaginal device containing 1g of progesterone (P4) for 8 days and 2mg of estradiol benzoate (EB) intramuscularly (IM) at device insertion (Day 0). At device removal (Day 8) 0.150mg of Sodium D-Cloprostenol was administered IM and the cows were randomly assigned to receive 1mg of EB (EB8) or 1mg of estradiol cypionate (EC8) IM, or to not receive any ovulatory inducer (Control). All the animals participated in all treatments (crossover). The interval from P4 removal to ovulation was shorter and less variable in the EB8 treatment group (P≤0.05). In Exp. 2 (crossover), multiparous cows (n=12) received the same hormonal treatment as the EB8 group in Exp.1. At device removal (Day 8) cows were randomly assigned to receive 300UI of eCG IM or to not receive eCG (Control). No difference was ascertained on follicular and luteal parameters in Exp. 2 (P>0.05). We concluded that EB can be used as the ovulatory inducer (Exp. 1) in a FTAI protocol in Curraleiro Pé-Duro cows. However, eCG (Exp. 2) was not able to stimulate follicular and luteal development. This result is probably due to the adaptive capacity of Curraleiro Pé-Duro cows that maintained a satisfactory body condition score even in dry and hot environments.


2010 ◽  
Vol 22 (1) ◽  
pp. 225
Author(s):  
V. G. Pinheiro ◽  
A. C. S. Oliveira ◽  
J. R. L. M. Cury ◽  
C. M. Barros

There are reports in the literature indicating that the presence of calf, body condition score, energy balance, number of births (multiparous v. primiparous), and breed are factors that influence the duration of postpartum anoestrus in beef cows. The purpose of the present study was to evaluate, during early postpartum, the time necessary for reestablishment of pituitary LH stocks, determined by the hypothalamic-pituitary axis responsiveness to exogenous administration of GnRH and estradiol benzoate (EB). Multiparous lactating Nelore cows (n = 51) were kept in Brachiaria brizantha pasture. The animals were randomly allocated in 8 groups, according to the hormonal treatment: EB Group (1.0 mg of EB, i.m. Estrogin®, Farmavet, Sao Paulo, Brazil; n = 7), EB and calf removal (CR) group (EB/CR, calves were removed at the time of birth, n = 4), EB/SUP group (cows were supplemented with a balanced diet, based on cotton meal and ground corn, from the beginning of the experiment until ovulation), GnRH group (100 μg, licereline, i.m. Gestran Plus®, ARSA SLR, Buenos Aires, Argentina; n = 7), GnRH/CR group (n = 4), GnRH/SUP group (n = 8), LH group (12.5 mg, i.m. Lutropin® Bioniche, Ontario, Canada; n = 7), and control group (did not receive any hormone to induce ovulation or diet supplementation, n = 5).The hormones were administered weekly, from 7 days postpartum (±5 days) until the occurrence of the first ovulation, which was determined by the presence of CL during weekly ovarian ultrasonography (Aloka 900, Tokyo, Japan, 7.5 MHz probe). The data were analyzed by ANOVA. On average (±SEM) the first ovulation occurred 86.7 ± 0.5 (EB); 19.7 ± 0.6 (EB/CR); 57.8 ± 0.4 (EB/SUP); 44.7 ± 0.5 (GnRH); 25.9 ± 0.6 (GnRH/CR); 32.8 ± 0.4 (GnRB/SUP); 42.4 ± 0.5 (LH); and 59.3 ± 0.5 (control) days postpartum. There were significant differences between groups: EB v. EB/SUP (P < 0.01), EB v. EB/CR (P < 0.01), EB v. control (P < 0.04), EB v. GnRH (P = 0.01), and there was a tendency between groups: GnRH v. GnRH-SUP (P = 0.10) and LH v. control (P = 0.10). The first ovulations were detected from the second week postpartum (animals from Groups GnRH and EB/CR) until the last ultrasound examination on Day 120 postpartum (Group EB). The results indicate that from the second week postpartum there is sufficient LH in the pituitary to induce ovulation after GnRH or EB administration. However, the cows from EB group ovulated later than animals from the other groups, possibly due to the sensitivity of hypothalamus to negative feedback of estrogens, inhibiting the pre-ovulatory LH surge. Additionally, calf removal and food supplementation reduced in 2 to 4 weeks the time of the first postpartum ovulation induced by GnRH or EB. Fellowship from FAPESP. Supported from FAPESP (Sao Paulo, Brazil).


2010 ◽  
Vol 22 (1) ◽  
pp. 242
Author(s):  
F. Z. Brandão ◽  
E. K. N. Arashiro ◽  
M. Henry ◽  
L. M. Figueira ◽  
J. M. G. Souza ◽  
...  

The development and use of non-invasive techniques would reduce risks of surgery sequels on the same animal and use of the donor could be optimized. The aim of this study was to evaluate the accuracy of ultrasonography performed prior to embryo collection to estimate superovulation response in sheep. Fifteen pluriparous Santa Inês sheep, 2 to 5 year old, with an average body weight of 46.79 ± 6.00 kg and body condition score of 2.96 ± 0.32 (1 to 5 scale) were allocated into 3 groups (GI, GII, GIII) in a cross-over design. In GI, intravaginal sponges (60 mg of medroxyprogesterone acetate; Progespon®, Schering Plough Animal Health, São Paulo, Brazil) were inserted (Day 0) and maintained for 14 days, and the superovulatory (SOV) protocol started on Day 12. In GII and GIII, intravaginal sponges were inserted (Day 0) and maintained for 6 days. On Day 5, the animals were treated with 300 IU of eCG (Novormon 5000®, Schering Plough Animal Health) and 5 mg of dinoprost (Lutalyse® Pfizer Animal Health, São Paulo, Brazil) i.m. Animals in GIII received 0.025 mg of gonadorelin acetate (Gestran-Plus®, Tecnopec, São Paulo, Brazil) i.m. 12 h after sponge withdrawal. In GII and GIII, the SOV protocol started 48 h after sponge removal and a new sponge was inserted immediately after its removal. The SOV protocol in all groups consisted of 200 mg of pFSH (Folltropin-V®, Tecnopec) administered in 6 decreasing doses given every 12 h (50/50, 30/30, and 20/20 mg). At the time of the fifth dose of pFSH, 5 mg of dinoprost was administered i.m. and the sponges were removed. Animals were bred by a sexually mature ram twice a day until the end of estrus. Prior to embryo collection, an ultrasonographic evaluation (5 MHz, Aloka SSD-500, Tokyo, Japan) was performed to determine the number of CL present on both ovaries. The number of CL was further evaluated by laparoscopy, when it was possible to detect poor responders or even non-ovulating animals. Statistical analysis was performed using all tests at the 95% confidence interval by SAEG program. Results are presented as mean ± SE. The number of CL was not different among all groups. The total number (GI, GII, and GIII) of CL determined by ultrasonography (9.09 ± 5.01) was not different (P > 0.05) from that observed by laparoscopy (8.87 ± 5.25). A significant correlation (r = 0.56, P < 0.0005) between evaluation performed by ultrasonography and laparoscopy was observed. These results suggest that ultrasonography can be used to determine the response to the superovulatory protocol. As embryo collection in sheep is performed mainly by surgical techniques, the implementation of non-invasive techniques such as ultrasonography could avoid unnecessary surgeries on animals that did not respond to the SOV protocol, therefore preventing early culling of embryo donors. Financial support: Fopesq/Proppi and Faperj (E26/171.065/2006).


2010 ◽  
Vol 22 (1) ◽  
pp. 161
Author(s):  
J. R. S. Torres-Júnior ◽  
J. A. T. Souza ◽  
M. I. S. Silva ◽  
J. S. Costa ◽  
G. S. Lima ◽  
...  

The duration of spermatic viability in the female reproductive system in cattle is 18 to 24 hours. Therefore, the time required for sperm capacitation in different bulls demonstrated to be highly variable and may affect the adequate amount of capacitated sperm within an optimal window of time for fertilization. The aim of this study was to evaluate the conception rate in Nelore cows inseminated with semen from a single bull compared with semen from a pool of 3 bulls (Fertility Plus®, ABS Pecplan, Minas Gerais, Brazil). On a random day of the estrous cycle (Day 0), 400 Nelore multiparous cows received a progesterone intravaginal device (1 g of P4, DIB®, Intervet/Schering-Plough, Cotia, Brazil) plus 2mg of estradiol benzoate (i.m. Estrogin®, Farmavet, São Paulo, Brazil). At the time of P4 device withdrawal (Day 8), 150 (ig of d-cloprostenol (i.m. Preloban®, Intervet/Schering-Plough), 1 mg of estradiol cypionate (i.m. ECP®, Pfizer, Brazil), and 300IU of eCG (i.m. Folligon®, Intervet/Schering-Plough) were administered. At 48 to 52 h after implant removal, all cows were fixed-time inseminated (FTAI). Then, cows were homogeneously distributed based on the semen used for FTAI in 4 groups: CONV1 (conventional dose of semen from bull 1), CONV2 (conventional dose of semen from bull 2), CONV3 (conventional dose of semen from bull 3), FERT (pool of semen from bulls 1, 2 and 3 homogeneously mixed in a single dose). Both conventional and Fertility Plus batches of semen contained a total dose of 30 × 106 spermatozoa. For pregnancy diagnosis, an ultrasonographic (CHISON 500VET, USP Brasil Eletromedicina, São Paulo, Brazil) examination was performed 30 days after the FTAI. Data were analyzed using the GENMOD procedure of SAS (SAS Institute, Cary, NC, USA). There was no interaction between treatment and body condition score [using a 1 (very thin) to 5 (very fat) point scale] or AI technician. The conception rates for CONV1, CONV2, CONV3, and FERT were, respectively, 40/101 (39.6%)b, 50/99 (50.5%)ab, 46/99 (46.5%)ab, 54/101 (53.5%)a; P < 0.05. In addition, the mean of conventional v. Fertility Plus treatments presented conception rates of 136/299 (45.5%) v. 54/101 (53.5%), respectively (P = 0.14). No significant statistical differences were observed between treatments. However, this trial showed that the utilization of the new Fertility Plus technology increased the overall conception rate by 8.0%. This probably implicates a complementary effect among semen samples and provides a greater time of sperm viability in oviduct. Also it provides evidence of the individual variation in capacitation time of bulls used for composition of the pool. Pooled semen of multiple sires may improve the reproductive performance at AI in cattle and increase the potential of the beef industry to produce pregnancies and born calves.


Sign in / Sign up

Export Citation Format

Share Document